Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission: To promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Dr. Eugenio Greco,
Increased atherothrombotic markers and endothelial dysfunction in steroid users CB Severo et al. European Journal of Preventive Cardiology, first published on February 3, 2012 doi:10.1177/2047487312437062
This “Cross-sectional study”, published in the European Journal of Preventive Cardiology, focuses on the association between the use of androgenic anabolic steroids and changes in atherothrombotic markers and endothelial function, which are compatible with increased cardiovascular risk. The Authors compared the data of 10 athletes who were users of androgenic anabolic steroids (confirmed by urine analysis), and 12 non-user athletes. The results of body mass, blood pressure, platelet count, HDLc, hs-CRP, follicle-stimulating hormone, flow-mediated dilation, were worse in androgenic anabolic steroids users compared with non-users.
The Authors conclude that there is an increased cardiovascular risk in athletes who were users of androgenic anabolic steroids compared to non-user athletes, due to important changes in blood lipids and inflammatory markers thus reducing the endothelial function.